Operating Lease, Right-of-Use Asset of Medpace Holdings, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Medpace Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Medpace Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $123,586,000, a 5.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Medpace Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $123,586,000 -$6,961,000 -5.3% 30 Sep 2025 10-Q 23 Oct 2025 2025 Q3
Q2 2025 $129,504,000 -$4,497,000 -3.4% 30 Jun 2025 10-Q 22 Jul 2025 2025 Q2
Q1 2025 $129,859,000 -$8,944,000 -6.4% 31 Mar 2025 10-Q 22 Apr 2025 2025 Q1
Q4 2024 $128,649,000 -$16,152,000 -11% 31 Dec 2024 10-Q 23 Oct 2025 2025 Q3
Q3 2024 $130,547,000 -$13,600,000 -9.4% 30 Sep 2024 10-Q 22 Oct 2024 2024 Q3
Q2 2024 $134,001,000 -$5,862,000 -4.2% 30 Jun 2024 10-Q 23 Jul 2024 2024 Q2
Q1 2024 $138,803,000 -$4,506,000 -3.1% 31 Mar 2024 10-Q 23 Apr 2024 2024 Q1
Q4 2023 $144,801,000 +$5,733,000 +4.1% 31 Dec 2023 10-K 11 Feb 2025 2024 FY
Q3 2023 $144,147,000 +$5,076,000 +3.6% 30 Sep 2023 10-Q 24 Oct 2023 2023 Q3
Q2 2023 $139,863,000 +$4,474,000 +3.3% 30 Jun 2023 10-Q 25 Jul 2023 2023 Q2
Q1 2023 $143,309,000 +$1,671,000 +1.2% 31 Mar 2023 10-Q 25 Apr 2023 2023 Q1
Q4 2022 $139,068,000 +$9,510,000 +7.3% 31 Dec 2022 10-K 13 Feb 2024 2023 FY
Q3 2022 $139,071,000 +$13,643,000 +11% 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 $135,389,000 +$24,659,000 +22% 30 Jun 2022 10-Q 26 Jul 2022 2022 Q2
Q1 2022 $141,638,000 +$29,372,000 +26% 31 Mar 2022 10-Q 26 Apr 2022 2022 Q1
Q4 2021 $129,558,000 +$15,749,000 +14% 31 Dec 2021 10-K 14 Feb 2023 2022 FY
Q3 2021 $125,428,000 +$15,895,000 +15% 30 Sep 2021 10-Q 26 Oct 2021 2021 Q3
Q2 2021 $110,730,000 -$2,836,000 -2.5% 30 Jun 2021 10-Q 27 Jul 2021 2021 Q2
Q1 2021 $112,266,000 +$53,599,000 +91% 31 Mar 2021 10-Q 27 Apr 2021 2021 Q1
Q4 2020 $113,809,000 +$61,657,000 +118% 31 Dec 2020 10-K 15 Feb 2022 2021 FY
Q3 2020 $109,533,000 +$57,054,000 +109% 30 Sep 2020 10-Q 27 Oct 2020 2020 Q3
Q2 2020 $113,566,000 +$61,757,000 +119% 30 Jun 2020 10-Q 28 Jul 2020 2020 Q2
Q1 2020 $58,667,000 +$6,515,000 +12% 31 Mar 2020 10-Q 29 Apr 2020 2020 Q1
Q4 2019 $52,152,000 +$52,152,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
Q3 2019 $52,479,000 30 Sep 2019 10-Q 29 Oct 2019 2019 Q3
Q2 2019 $51,809,000 30 Jun 2019 10-Q 30 Jul 2019 2019 Q2
Q1 2019 $52,152,000 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q4 2018 $0 31 Dec 2018 10-K 25 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.